COVID-19 Vaccine

Current Eligibility Criteria

Last updated: April 9, 2021

Super-Sites and Pop-up Clinics

Book your COVID-19 vaccine appointment online

If you are eligible to be immunized, you can now book your vaccine appointment online for any of our supersites, quickly and conveniently.

To book, you'll need to create an account with your email address and health card number.  You can link more than one person to the same account, so that you can book for family members and loved ones as they become eligible.  Please note that only first-dose appointments should be booked at this time.

Book your COVID-19 vaccine appointment online

Once you have booked an appointment, don’t forget to print and complete your consent form.

If you don't have an email address, the call centre continues to be available at 1-844-626-8222 (1-844-MAN-VACC) to book appointments at supersites and pop-up clinics. Daily hours of operation are from 6:00 a.m. to 8:00 p.m.

Only individuals who are eligible can call or book an appointment online for immunization. You will be screened to ensure you meet current eligibility.

  • 60 years of age and older (NEW: expanded from age 62)
  • 40 years of age and older for First Nation people (NEW: expanded from age 42)
  • individuals aged 18 or older are eligible to be immunized if they work in these settings, regardless of profession or role:
    • acute care facilities;
    • COVID-19 immunization clinics, testing sites, or alternative isolation accommodations facilities;
    • licensed personal care homes;
    • congregate living facilities, including addictions treatment, supportive housing, assisted living, seniors living, elderly housing, group homes and provincial or federal correctional facilities;
    • emergency response services and patient transport, 
    • outpatient health-care settings, including all types of outpatient health care clinics such as: 
      • diagnostic imaging, 
      • laboratories, 
      • blood donor centres, 
      • surgical centres, 
      • elderly day programs and 
      • home based care.
    • congregate group care settings such as homeless shelters, family violence shelters, emergency placement shelters and second stage housing;
    • congregate group care settings in Community Living disABILITY Services or the child and family services sector (Manitoba Families is identifying eligible staff and contact them directly to schedule appointments); 
    • home-care workers employed by a regional health authority (RHA), a RHA-contracted service provider, or a self- and family-managed care client; or
    • laboratories which handle COVID-19 specimens.

Questions and Answers:

I am employed by an eligible setting, but I work from home.  Am I eligible to be immunized?
If you have been working from home but will return to your workplace setting, then you are eligible to be immunized. 

I work part time.  Is there a set amount of hours or shifts I have to work before I am eligible?
You are eligible to be immunized. There is no minimum amount of shifts or hours for people who work in an eligible setting.

I don’t see my specific profession or job listed. Am I eligible?
Eligibility is based on the workplace setting, not specific jobs or roles.  If you work in an eligible setting, you can make an appointment.

I am a healthcare student and have to do a practicum in an eligible setting. Am I eligible?

I am a contracted employee, volunteer or independent consultant.  However, I go into eligible settings for my work.  Am I eligible?
Yes. If you are working in an eligible setting, you are eligible to be immunized.  You do not have to be directly employed to be eligible.  

I go to people’s homes to provide health care services, like foot care nursing, which are not part of home care.  Am I eligible?

How are eligible congregate living settings determined?
Congregate living settings are places where people share space for living, eating or sleeping.  Residents at congregate living settings are immunized by focused immunization teams.  This work is prioritized based on the number and ages of residents and the ability to follow public health measures. 

I am under 18, but I work in an eligible workplace setting. Can I get the vaccine?
No. Manitoba is immunizing people aged 18 or older.

I have an appointment but I can’t go. Can I give my appointment to someone else?
Your appointment is made in your name and is not transferrable.  If you’re unable to attend, please call or go online to reschedule.

I visit an eligible workplace for business purposes (sales or deliveries, for example).  Am I eligible?
No.  You must work in an eligible workplace.  Visitors to those locations are not eligible.

Medical Clinics and Pharmacies

The AstraZeneca/COVISHIELD vaccine is used to provide COVID-19 vaccines in doctors’ offices and pharmacies. Manitoba public health officials have developed guidance for the use of the AstraZeneca/Covishield vaccine.

Eligibility Criteria

Updated April 7 - Manitobans aged 65 and older are now eligible to receive the AstraZeneca/Covishield vaccine at a participating medical clinic or pharmacy.  Priority should be given to people in this age group who might face barriers in accessing a supersite or pop-up clinic.

Manitobans aged 55 to 64 with a specified high-risk condition continue to be eligible to receive the AstraZeneca/Covishield COVID-19 vaccine.

People with a condition in Priority List 1 should be offered immunization before those with a condition in Priority List 2.

Priority List 1:

  • Individuals with the following chronic health conditions:
    • end stage renal disease undergoing hemodialysis OR peritoneal dialysis
    • cirrhosis due to any cause OR portal hypertension
    • heart failure (class III/IV ), ventricular assist device OR adult congenital heart disease stage C and D
    • severe COPD, pulmonary hypertension, pulmonary fibrosis, interstitial lung disease OR cystic fibrosis
    • history of cerebral vascular accident with residual deficits
    • malignant hematologic disorders including leukemia and lymphoma OR clonal blood disorder
    • malignant neoplasms (solid tissue) who will receive or are currently receiving immunosuppressive therapy including chemotherapy
    • severe obesity (BMI ≥ 40)
    • receiving one or more of the following immunosuppressive therapies: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors, chronic dose prednisone >=20mg/day, mycophenolate, sulfasalazine and JAK inhibitors (e.g., tofacitinib)
    • solid organ or hematopoietic stem cell transplant (candidate or recipient)
    • trisomy 21 (Down syndrome)
    • asplenia or hyposplenism (including sickle cell disease)
  • Individuals receiving home care ≥ 4 times/week OR receive 24/7 support from Community Living Disability Services.

Priority List 2:

  • Individuals with the following chronic health conditions:
    • Chronic cardiovascular disease including heart failure (class I/II), coronary artery disease, malignant tachyarrythmia OR cardiomyopathies
    • chronic liver disease
    • chronic neurologic OR neurodevelopmental conditions including cerebral palsy, Parkinson’s disease, multiple sclerosis, ALS OR dementia (including Alzheimer’s disease)
    • chronic pulmonary disease including COPD OR severe and/or uncontrolled asthma
    • chronic renal disease
    • HIV (CD4 cell count ≥ 200 x 106/L and CD4 percentage ≥ 15%)
    • severe systemic autoimmune disorders (e.g., systemic lupus erythematosus, scleroderma, myocarditis, rheumatoid arthritis)
    • type 1 or 2 diabetes mellitus (poorly controlled and/or with complications)
    • active tuberculosis (current or previous) OR current latent tuberculosis (LTBI)
    • receiving immunosuppressing therapy
  • Individuals receiving homecare ≤ 3 times/week OR any level of Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).
  • Household contacts of individuals with Priority 1 chronic health conditions OR designated support person(s) for personal care home residents (in the authorized age category).
March 29, 2021 - Update on the use of the AstraZeneca/Covishield vaccine in Manitoba